curium pharma

Private

Last Round

Private Equity

Dec 2, 2020

Last Round Size

$1.43B

Est. Valuation

$3.57B

Total Funding Raised

$1.43B

Company Overview

Developer and manufacturer of radiopharmaceutical products for diagnosing and treating cancer, heart, brain, and bone diseases.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Compare curium pharma with similar companies based on industry and business-model similarity.

No public comparables are available for curium pharma. Request access to learn about comparables coverage.

Historical fundraising activity

Explore SEC and related filing metadata, where available.

curium pharma filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Headquarters—

Year Founded2017

Last FundingDec 2, 2020

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?